Esperion Therapeutics, Inc. Profile Avatar - Palmy Investing

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoi…

Drug Manufacturers - Specialty & Generic
US, Ann Arbor [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ESPR's Analysis
CIK: 1434868 CUSIP: 29664W105 ISIN: US29664W1053 LEI: - UEI: -
Secondary Listings
ESPR has no secondary listings inside our databases.